We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+6.89%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$53.9B
AUM Growth
-$1.63B
(-2.9%)
Cap. Flow
-$3.55B
Cap. Flow
% of AUM
-6.58%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,489
New
41
Increased
394
Reduced
550
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$74.8M |
| 2 |
Sysco
SYY
|
+$54M |
| 3 |
ExxonMobil
XOM
|
+$42.4M |
| 4 |
Progressive
PGR
|
+$40.9M |
| 5 |
Mondelez International
MDLZ
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.68B |
| 2 |
Broadcom
AVGO
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Canadian Natural Resources
CNQ
|
+$77.6M |
| 5 |
Gilead Sciences
GILD
|
+$60.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.08% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
COPT Defense Properties
CDP
$4.13B
| $812K | ﹤0.01% |
26,964
| – | – |
|
927
Kymera Therapeutics
KYMR
$9.11B
| $801K | ﹤0.01% |
23,562
| – | – |
|
928
Regenxbio
RGNX
$703M
| $795K | ﹤0.01% |
74,600
| – | – |
|
929
HUTCHMED
HCM
$2.17B
| $785K | ﹤0.01% |
41,362
| – | – |
|
930
ImmunityBio
IBRX
$8.05B
| $782K | ﹤0.01% |
196,200
| – | – |
|
931
Apple Hospitality REIT
APLE
$3.68B
| $765K | ﹤0.01% |
51,325
| – | – |
|
|
AAT
932
American Assets Trust
AAT
$1.37B
| $763K | ﹤0.01% |
35,179
+9,620
| +38% | +$244K |
|
933
Insight Enterprises
NSIT
$4.43B
| $744K | ﹤0.01% |
3,529
| – | – |
|
934
VF Corp
VFC
$5.81B
| $741K | ﹤0.01% |
38,110
| – | – |
|
935
BW LPG
BWLP
$3.23B
| $740K | ﹤0.01% |
50,012
+12,622
| +34% | +$198K |
|
936
Fortrea Holdings
FTRE
$1.86B
| $738K | ﹤0.01% |
38,219
| – | – |
|
937
Arrowhead Research
ARWR
$12.6B
| $737K | ﹤0.01% |
37,844
+1,609
| +4% | +$39.3K |
|
938
Crane Co
CR
$12.7B
| $730K | ﹤0.01% |
4,709
| – | – |
|
939
Kontoor Brands
KTB
$4.14B
| $725K | ﹤0.01% |
8,904
| – | – |
|
940
Tanger
SKT
$4.43B
| $724K | ﹤0.01% |
25,340
| – | – |
|
941
Wolfspeed
WOLF
$1.57B
| $722K | ﹤0.01% |
72,690
-20,209
| -22% | -$298K |
|
942
Jones Lang LaSalle
JLL
$16.7B
| $720K | ﹤0.01% |
2,712
-982
| -27% | -$238K |
|
|
COOP
943
DELISTED
Mr. Cooper
COOP
| $715K | ﹤0.01% |
7,931
| – | – |
|
944
Protagonist Therapeutics
PTGX
$9.6B
| $709K | ﹤0.01% |
15,800
| – | – |
|
945
FirstCash
FCFS
$9.04B
| $703K | ﹤0.01% |
6,200
| – | – |
|
|
GAP
946
The Gap Inc
GAP
$7.55B
| $698K | ﹤0.01% |
32,756
-4,846
| -13% | -$108K |
|
947
e.l.f. Beauty
ELF
$5.61B
| $697K | ﹤0.01% |
6,290
+2,826
| +82% | +$443K |
|
948
LXP Industrial Trust
LXP
$3.58B
| $692K | ﹤0.01% |
13,861
| – | – |
|
949
Unity
U
$19.3B
| $691K | ﹤0.01% |
30,568
+3,727
| +14% | +$64.4K |
|
950
Supernus Pharmaceuticals
SUPN
$2.73B
| $674K | ﹤0.01% |
22,200
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2024 Portfolio in Review
As of Q3 2024, DekaBank Deutsche Girozentrale held 1,489 positions worth $53.9B, down 2.9% from $55.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
DekaBank Deutsche Girozentrale withdrew a net $3.55B in Q3 2024, closing 60 positions and reducing 550 holdings. Its most notable exit was Labcorp, an estimated $36.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.
Against the trend, DekaBank Deutsche Girozentrale opened a new position in SolarEdge worth $1.5M.
- DekaBank Deutsche Girozentrale's largest Q3 2024 buy was SolarEdge: 66,000 shares worth $1.5M.
- DekaBank Deutsche Girozentrale added most to CVS Health in Q3 2024, an estimated $74.8M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.68B.
- DekaBank Deutsche Girozentrale fully exited Labcorp in Q3 2024, selling an estimated $36.3M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 26% of its $53.9B portfolio in Q3 2024.
- DekaBank Deutsche Girozentrale opened 41 new positions and closed 60 in Q3 2024.
- DekaBank Deutsche Girozentrale's portfolio value fell 2.9% quarter-over-quarter to $53.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2024, filed 24 Oct 2024.